Vancomycin plus rifampicin for methicillin-resistant Staphylococcus aureus pneumonia benefits only those who have no development of rifampicin resistance during treatment

Tan C.-K.Lai C.-C.Lin S.-H.PO-REN HSUEH2020-12-182020-12-1820100090-3493https://scholars.lib.ntu.edu.tw/handle/123456789/528601Vancomycin plus rifampicin for methicillin-resistant Staphylococcus aureus pneumonia benefits only those who have no development of rifampicin resistance during treatmentletter10.1097/CCM.0b013e3181db7d28206478092-s2.0-77954934624